Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kelly Maloney

Concepts (360)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
2025
278
6.000
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
2024
75
1.560
 Why?
Antineoplastic Combined Chemotherapy Protocols
17
2025
1565
1.390
 Why?
Down Syndrome
6
2023
472
1.360
 Why?
Burkitt Lymphoma
3
2024
56
1.000
 Why?
Asparaginase
8
2020
29
0.900
 Why?
Leukemia, Myeloid, Acute
6
2024
592
0.800
 Why?
Child
71
2025
20853
0.780
 Why?
Consolidation Chemotherapy
2
2019
9
0.700
 Why?
Child, Preschool
47
2024
10507
0.640
 Why?
Disease-Free Survival
12
2024
647
0.600
 Why?
Leukemia
4
2021
230
0.580
 Why?
Oncogene Proteins, Fusion
6
2024
201
0.570
 Why?
Mercaptopurine
5
2017
15
0.540
 Why?
Neoplasm Recurrence, Local
5
2024
959
0.540
 Why?
Antineoplastic Agents
7
2019
2058
0.500
 Why?
Prognosis
15
2024
3791
0.490
 Why?
Preleukemia
1
2015
2
0.480
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
118
0.480
 Why?
Drug Hypersensitivity
3
2017
81
0.470
 Why?
Infant
34
2024
9016
0.460
 Why?
Molecular Targeted Therapy
3
2021
389
0.460
 Why?
Leukemia, Monocytic, Acute
1
2014
4
0.450
 Why?
Sarcoma, Myeloid
1
2014
4
0.450
 Why?
Recurrence
11
2024
1005
0.450
 Why?
Neoplasm, Residual
7
2023
119
0.430
 Why?
Adolescent
40
2024
20371
0.410
 Why?
Bone Marrow Transplantation
1
2014
274
0.400
 Why?
Medical Oncology
5
2025
272
0.400
 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
26
0.390
 Why?
Erwinia
2
2020
3
0.380
 Why?
Humans
83
2025
129212
0.380
 Why?
Tumor Suppressor Proteins
3
1999
317
0.380
 Why?
Acute Kidney Injury
1
2019
789
0.370
 Why?
Chromosome Aberrations
2
2022
150
0.370
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
573
0.360
 Why?
Neutropenia
2
2022
134
0.360
 Why?
Male
55
2024
63491
0.360
 Why?
Stem Cell Transplantation
3
2019
166
0.350
 Why?
Rhabdomyosarcoma
1
2011
64
0.340
 Why?
Cell Cycle Proteins
3
1999
586
0.340
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
112
0.340
 Why?
Carrier Proteins
3
1999
740
0.330
 Why?
Sarcoma, Ewing
1
2011
89
0.330
 Why?
Ploidies
2
2019
17
0.320
 Why?
Catheter-Related Infections
2
2022
71
0.310
 Why?
Survival Rate
8
2024
1874
0.310
 Why?
Core Binding Factor Alpha 2 Subunit
3
2021
32
0.310
 Why?
Genes, Tumor Suppressor
2
1999
86
0.300
 Why?
Cyclophosphamide
4
2019
229
0.300
 Why?
Female
53
2024
68600
0.290
 Why?
Catheterization, Central Venous
2
2022
103
0.290
 Why?
Philadelphia Chromosome
2
2018
18
0.280
 Why?
Medication Adherence
3
2017
558
0.260
 Why?
Gene Deletion
2
1998
378
0.260
 Why?
Vincristine
4
2021
109
0.260
 Why?
Trisomy
2
2021
77
0.250
 Why?
Neoplasm Proteins
2
2018
424
0.250
 Why?
Antimetabolites, Antineoplastic
2
2017
91
0.250
 Why?
Etoposide
2
2019
148
0.250
 Why?
Young Adult
15
2024
12396
0.240
 Why?
Treatment Outcome
12
2023
10189
0.230
 Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
69
0.220
 Why?
Anxiety
3
2016
959
0.220
 Why?
PAX5 Transcription Factor
2
2024
14
0.220
 Why?
Health Equity
1
2024
82
0.200
 Why?
Gene Rearrangement
3
2019
148
0.200
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
64
0.200
 Why?
Polyethylene Glycols
5
2020
601
0.190
 Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
3
0.190
 Why?
Induction Chemotherapy
2
2019
70
0.190
 Why?
Central Venous Catheters
1
2022
48
0.190
 Why?
Lymphoma
1
2023
195
0.190
 Why?
Doxorubicin
2
2022
325
0.180
 Why?
Adult
23
2023
35464
0.180
 Why?
Program Evaluation
2
2017
873
0.180
 Why?
Prednisone
2
2019
232
0.180
 Why?
Lung Neoplasms
1
2014
2339
0.180
 Why?
Translocation, Genetic
2
2013
97
0.170
 Why?
Polymorphism, Single Nucleotide
3
2017
2071
0.170
 Why?
Maintenance Chemotherapy
2
2017
22
0.170
 Why?
Genomics
3
2024
715
0.170
 Why?
Bacterial Infections
1
2022
235
0.170
 Why?
Risk Factors
11
2022
9747
0.170
 Why?
Immunocompromised Host
1
2021
197
0.160
 Why?
Diploidy
1
2019
13
0.160
 Why?
Quality of Life
3
2024
2693
0.160
 Why?
Genes, p16
1
1999
19
0.160
 Why?
Hyperglycemia
1
2023
327
0.160
 Why?
Prospective Studies
9
2022
7103
0.150
 Why?
Chromosomes, Human, Pair 19
1
1998
23
0.150
 Why?
Myelodysplastic Syndromes
1
2020
129
0.150
 Why?
Antibodies, Bispecific
1
2019
49
0.150
 Why?
Chromosomes, Human, Pair 17
1
1998
54
0.150
 Why?
Rituximab
1
2019
162
0.150
 Why?
Chromosomes, Human, Pair 1
1
1998
71
0.150
 Why?
Mutagenesis
1
1999
181
0.150
 Why?
Patient Safety
1
2021
286
0.150
 Why?
Prostate-Specific Antigen
2
2009
162
0.140
 Why?
Substance Withdrawal Syndrome
1
2020
174
0.140
 Why?
Proto-Oncogenes
1
1997
29
0.140
 Why?
Family Relations
2
2016
88
0.140
 Why?
Thioguanine
1
2017
18
0.140
 Why?
Thionucleotides
1
2017
34
0.140
 Why?
Oncologists
1
2017
35
0.140
 Why?
Apyrase
1
2017
16
0.140
 Why?
Follow-Up Studies
6
2021
4886
0.130
 Why?
Blast Crisis
1
2016
33
0.130
 Why?
Carboxypeptidases A
1
2016
2
0.130
 Why?
Retrospective Studies
10
2023
14488
0.130
 Why?
Pediatricians
1
2017
129
0.130
 Why?
Depression
2
2016
1302
0.130
 Why?
Sepsis
1
2022
571
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
287
0.120
 Why?
Osteonecrosis
1
2015
22
0.120
 Why?
Mentors
2
2017
178
0.120
 Why?
Adrenal Cortex Hormones
1
2019
519
0.120
 Why?
Nausea
1
2016
108
0.120
 Why?
Central Nervous System Neoplasms
1
2017
149
0.120
 Why?
Pancreatitis
1
2016
129
0.120
 Why?
Longitudinal Studies
7
2016
2713
0.120
 Why?
Mentoring
1
2017
130
0.120
 Why?
Mutation
4
2022
3715
0.120
 Why?
Monitoring, Physiologic
1
2017
268
0.120
 Why?
Dexamethasone
4
2021
346
0.120
 Why?
Fusion Proteins, bcr-abl
2
2016
69
0.120
 Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
16
0.110
 Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
71
0.110
 Why?
Cross Infection
1
2016
216
0.110
 Why?
High-Throughput Nucleotide Sequencing
1
2017
487
0.110
 Why?
Antigens, CD
1
2017
488
0.110
 Why?
Bacteremia
1
2016
197
0.110
 Why?
Flow Cytometry
1
2018
1156
0.110
 Why?
Repressor Proteins
1
1997
406
0.110
 Why?
Pediatrics
3
2021
1052
0.110
 Why?
Immunotherapy
1
2018
592
0.110
 Why?
Life Change Events
1
2014
148
0.110
 Why?
Histone-Lysine N-Methyltransferase
2
2010
125
0.110
 Why?
Chromosomes, Human, Pair 21
1
2013
43
0.100
 Why?
DNA-Binding Proteins
2
1998
1443
0.100
 Why?
Venous Thromboembolism
1
2017
283
0.100
 Why?
Quality Improvement
1
2021
1100
0.100
 Why?
Transcription Factors
2
1998
1649
0.100
 Why?
Leukemia, Megakaryoblastic, Acute
1
2012
10
0.100
 Why?
Self Report
1
2017
799
0.100
 Why?
Karyotyping
3
2019
107
0.100
 Why?
Myeloproliferative Disorders
1
2012
26
0.100
 Why?
Contraindications
1
2012
90
0.100
 Why?
Arabinonucleosides
1
2011
8
0.100
 Why?
Adenine Nucleotides
1
2011
22
0.090
 Why?
Cohort Studies
5
2021
5408
0.090
 Why?
Antibodies, Monoclonal
1
2018
1364
0.090
 Why?
Prostatic Neoplasms
2
2009
1016
0.090
 Why?
Chromosomes, Human, Pair 10
1
2010
18
0.090
 Why?
Chromosomes, Human, Pair 4
1
2010
29
0.090
 Why?
Multivariate Analysis
4
2015
1500
0.080
 Why?
Pain
1
2016
770
0.080
 Why?
T-Lymphocytes
1
2018
1928
0.080
 Why?
Parents
2
2016
1306
0.080
 Why?
Age Factors
8
2019
3137
0.080
 Why?
Prostatectomy
1
2009
106
0.080
 Why?
Bloom Syndrome
1
1988
1
0.080
 Why?
Neoplasm Metastasis
1
2011
610
0.080
 Why?
Risk Assessment
4
2024
3234
0.070
 Why?
Gene Expression Regulation, Leukemic
2
2016
50
0.070
 Why?
Juxtaglomerular Apparatus
1
2007
1
0.070
 Why?
Polymerase Chain Reaction
1
2010
1036
0.070
 Why?
Blood Coagulation
1
2008
238
0.070
 Why?
Drug Administration Schedule
2
2017
767
0.060
 Why?
Surveys and Questionnaires
4
2024
5387
0.060
 Why?
Clinical Trials as Topic
2
2024
1004
0.060
 Why?
Stress, Psychological
1
2014
1064
0.060
 Why?
Methotrexate
2
2017
249
0.060
 Why?
Remission Induction
2
2019
269
0.060
 Why?
Case-Control Studies
3
2024
3372
0.060
 Why?
Drug Monitoring
2
2017
216
0.060
 Why?
Acute Disease
2
2019
977
0.060
 Why?
Selection Bias
1
2024
37
0.060
 Why?
Personal Satisfaction
2
2017
199
0.050
 Why?
Administration, Oral
2
2017
783
0.050
 Why?
Kidney Neoplasms
1
2007
350
0.050
 Why?
Genetic Variation
1
1988
937
0.050
 Why?
Risk
5
2023
854
0.050
 Why?
Randomized Controlled Trials as Topic
2
2020
1360
0.050
 Why?
Disease Progression
2
2021
2622
0.050
 Why?
Proto-Oncogene Proteins c-cbl
1
2022
11
0.050
 Why?
Incidence
2
2019
2638
0.050
 Why?
Transcriptome
2
2019
885
0.050
 Why?
Exome
1
2022
220
0.050
 Why?
Menorrhagia
1
2001
20
0.050
 Why?
Drug Therapy
1
2021
78
0.050
 Why?
Diarrhea
2
1999
180
0.040
 Why?
Bone Marrow
1
2022
270
0.040
 Why?
Endocrine Glands
1
1979
15
0.040
 Why?
Blood Cell Count
1
1999
52
0.040
 Why?
Chromosomes, Human
1
2019
41
0.040
 Why?
Viral Load
1
2021
448
0.040
 Why?
Azacitidine
1
2020
139
0.040
 Why?
Loss of Heterozygosity
1
1999
46
0.040
 Why?
Cytogenetic Analysis
1
2019
33
0.040
 Why?
Genome-Wide Association Study
2
2016
1332
0.040
 Why?
Mosaicism
1
2019
71
0.040
 Why?
Disinfectants
1
1999
35
0.040
 Why?
Sequence Deletion
1
1999
178
0.040
 Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
215
0.040
 Why?
Infant, Newborn
4
2019
5753
0.040
 Why?
National Cancer Institute (U.S.)
1
2018
43
0.040
 Why?
Chromosomes
1
2019
101
0.040
 Why?
Interviews as Topic
1
2021
717
0.040
 Why?
Hypertension
1
2007
1240
0.040
 Why?
United States
4
2021
13873
0.040
 Why?
Overweight
1
2023
529
0.040
 Why?
Escherichia coli O157
1
1998
31
0.040
 Why?
Methylation
1
1998
230
0.040
 Why?
Community Participation
1
1999
124
0.040
 Why?
Genetic Predisposition to Disease
2
2017
2281
0.040
 Why?
Biopsy
1
2021
1087
0.040
 Why?
Erythrocyte Count
1
2017
19
0.040
 Why?
Public Health Surveillance
1
2017
68
0.040
 Why?
Glucose
1
2023
1000
0.040
 Why?
Escherichia coli Infections
1
1998
112
0.030
 Why?
Injections, Intramuscular
1
2017
116
0.030
 Why?
Food-Drug Interactions
1
2017
9
0.030
 Why?
Leucovorin
1
2017
69
0.030
 Why?
Proto-Oncogene Proteins c-ets
1
1997
53
0.030
 Why?
Career Mobility
1
2017
68
0.030
 Why?
Family
1
2021
653
0.030
 Why?
Feasibility Studies
1
2021
864
0.030
 Why?
Cranial Irradiation
1
2017
68
0.030
 Why?
Water Purification
1
1999
146
0.030
 Why?
Dairy Products
1
2017
36
0.030
 Why?
Cerebrospinal Fluid
1
2017
90
0.030
 Why?
MEF2 Transcription Factors
1
2016
61
0.030
 Why?
Hemorrhage
1
2001
677
0.030
 Why?
Infusions, Intravenous
1
2017
398
0.030
 Why?
Sulfonamides
1
2020
496
0.030
 Why?
NIH 3T3 Cells
1
2016
141
0.030
 Why?
Luciferases
1
2016
148
0.030
 Why?
Leukocyte Count
1
2017
325
0.030
 Why?
Methyltransferases
1
2017
70
0.030
 Why?
Methyl Ethers
1
1996
9
0.030
 Why?
Ethers
1
1996
16
0.030
 Why?
Bone Morphogenetic Protein 7
1
2015
9
0.030
 Why?
Anesthetics, Inhalation
1
1996
23
0.030
 Why?
Fluorides
1
1996
50
0.030
 Why?
Breast Neoplasms
5
1979
2142
0.030
 Why?
Middle Aged
10
2019
31075
0.030
 Why?
Cytarabine
1
2016
57
0.030
 Why?
Health Education
1
1999
333
0.030
 Why?
Genotype
3
2017
1839
0.030
 Why?
Severity of Illness Index
2
2017
2736
0.030
 Why?
Disease Management
1
2019
586
0.030
 Why?
Alternative Splicing
1
2017
218
0.030
 Why?
Histone Deacetylase Inhibitors
1
2016
209
0.030
 Why?
Qualitative Research
1
2021
1227
0.030
 Why?
Homeodomain Proteins
1
1998
494
0.030
 Why?
Intensive Care Units, Pediatric
1
2016
203
0.030
 Why?
Promoter Regions, Genetic
1
1999
1206
0.030
 Why?
HEK293 Cells
1
2017
693
0.030
 Why?
Sequence Analysis, RNA
1
2016
428
0.030
 Why?
Biomarkers, Tumor
1
2021
1181
0.030
 Why?
DNA Methylation
1
1999
607
0.030
 Why?
Aged
9
2019
22030
0.030
 Why?
Algorithms
1
2021
1618
0.030
 Why?
Psychomotor Agitation
1
2014
64
0.030
 Why?
Behavior
1
2014
92
0.030
 Why?
Marriage
1
2014
113
0.030
 Why?
Demography
1
2014
278
0.030
 Why?
Income
1
2014
189
0.030
 Why?
Blood Glucose
1
2023
2094
0.030
 Why?
Base Sequence
1
2016
2141
0.030
 Why?
Odds Ratio
1
2015
1023
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2013
315
0.020
 Why?
Aggression
1
2014
195
0.020
 Why?
Nucleoside Transport Proteins
1
2011
7
0.020
 Why?
Time Factors
2
2015
6549
0.020
 Why?
Regression Analysis
1
2014
993
0.020
 Why?
Erythrocytes
1
2017
672
0.020
 Why?
Antineoplastic Agents, Alkylating
1
2011
69
0.020
 Why?
Escherichia coli
1
2015
773
0.020
 Why?
Mice
2
2019
16861
0.020
 Why?
Antineoplastic Agents, Phytogenic
1
2011
187
0.020
 Why?
Survival Analysis
1
2013
1271
0.020
 Why?
Logistic Models
1
2015
1983
0.020
 Why?
Bacteria
1
2016
815
0.020
 Why?
Obesity
1
2023
2876
0.020
 Why?
Prevalence
1
2016
2559
0.020
 Why?
Kaplan-Meier Estimate
1
2011
857
0.020
 Why?
Emotions
1
2014
535
0.020
 Why?
Sister Chromatid Exchange
1
1988
4
0.020
 Why?
Genetic Complementation Test
1
1988
63
0.020
 Why?
Cell Fusion
1
1988
51
0.020
 Why?
Mice, Inbred C57BL
1
2019
5408
0.020
 Why?
Protein C
1
2008
47
0.020
 Why?
Water Microbiology
2
1999
85
0.020
 Why?
Plasminogen Activator Inhibitor 1
1
2008
84
0.020
 Why?
Antithrombins
1
2008
58
0.020
 Why?
Fibrinogen
1
2008
164
0.020
 Why?
Genetic Markers
1
1988
338
0.020
 Why?
Transplantation, Homologous
1
2008
401
0.020
 Why?
Biopsy, Needle
1
2007
189
0.020
 Why?
Renin-Angiotensin System
1
2007
80
0.020
 Why?
Rare Diseases
1
2007
100
0.020
 Why?
Blood Pressure Determination
1
2007
148
0.020
 Why?
Biomarkers
1
2017
3968
0.020
 Why?
Nephrectomy
1
2007
160
0.020
 Why?
Animals
2
2019
35219
0.020
 Why?
RNA, Messenger
1
2011
2702
0.010
 Why?
Immunohistochemistry
1
2007
1696
0.010
 Why?
Cell Line
1
1988
2777
0.010
 Why?
Anemia, Hypochromic
1
2001
4
0.010
 Why?
Blood Platelet Disorders
1
2001
10
0.010
 Why?
von Willebrand Diseases
1
2001
23
0.010
 Why?
Estriol
1
1979
7
0.010
 Why?
Estrone
1
1979
36
0.010
 Why?
Menstruation
1
1979
44
0.010
 Why?
Prolactin
1
1979
98
0.010
 Why?
Thrombocytopenia
1
2001
186
0.010
 Why?
Bolivia
1
1999
63
0.010
 Why?
Luteinizing Hormone
1
1979
179
0.010
 Why?
Follicle Stimulating Hormone
1
1979
236
0.010
 Why?
Restaurants
1
1998
20
0.010
 Why?
Swimming
1
1998
47
0.010
 Why?
Progesterone
1
1979
243
0.010
 Why?
Food Handling
1
1998
60
0.010
 Why?
Disease Transmission, Infectious
1
1998
55
0.010
 Why?
Water Supply
1
1998
74
0.010
 Why?
Meat
1
1998
93
0.010
 Why?
Estradiol
1
1979
492
0.010
 Why?
Halothane
1
1996
6
0.010
 Why?
Analysis of Variance
1
1999
1285
0.010
 Why?
Population Surveillance
1
1999
436
0.010
 Why?
Feces
1
1998
440
0.010
 Why?
Ovarian Neoplasms
1
1978
487
0.010
 Why?
Pedigree
3
1978
487
0.010
 Why?
Kidney
1
1996
1375
0.000
 Why?
Aged, 80 and over
1
1999
7061
0.000
 Why?
Nebraska
2
1976
10
0.000
 Why?
New York
2
1976
127
0.000
 Why?
Genes
1
1978
226
0.000
 Why?
Genetic Linkage
1
1978
299
0.000
 Why?
Oncogenic Viruses
1
1976
3
0.000
 Why?
Apocrine Glands
1
1976
4
0.000
 Why?
Genetic Techniques
1
1976
63
0.000
 Why?
Pheochromocytoma
1
1976
57
0.000
 Why?
Klinefelter Syndrome
1
1976
56
0.000
 Why?
Syndrome
1
1976
339
0.000
 Why?
Statistics as Topic
1
1976
306
0.000
 Why?
Pregnancy
2
1978
6384
0.000
 Why?
HLA Antigens
1
1976
234
0.000
 Why?
Abnormalities, Multiple
1
1976
178
0.000
 Why?
Skin Diseases
1
1976
142
0.000
 Why?
Sarcoma
1
1976
176
0.000
 Why?
Sex Factors
1
1978
1961
0.000
 Why?
Thyroid Neoplasms
1
1976
309
0.000
 Why?
Neoplasms
2
1976
2467
0.000
 Why?
Melanoma
1
1976
729
0.000
 Why?
Registries
1
1976
1886
0.000
 Why?
Phenotype
1
1976
3074
0.000
 Why?
Brain Neoplasms
1
1976
1170
0.000
 Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (360) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)